legislation: 114-hr-6347

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
114-hr-6347 114 hr 6347 To extend for one year the program for priority review to encourage treatments for rare pediatric diseases. Health 2016-11-17 2016-11-17 Referred to the House Committee on Energy and Commerce. House Rep. Grayson, Alan [D-FL-9] FL D G000556 0 This bill amends the Federal Food, Drug, and Cosmetic Act to extend through 2017 the priority review voucher program for treatments for rare pediatric diseases. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration within six months.) 2023-01-11T13:34:03Z  

Links from other tables